The summary of the results of the clinical trial for laypersons shall contain information on the following elements:
Clinical trial identification (including title of the trial, protocol number, EU trial number and other identifiers);
Name and contact details of the sponsor;
General information about the clinical trial (including where and when the trial was conducted, the main objectives of the trial and an explanation of the reasons for conducting it);
Population of subjects (including information on the number of subjects included in the trial in the Member State concerned, in the Union and in third countries; age group breakdown and gender breakdown; inclusion and exclusion criteria);
Investigational medicinal products used;
Description of adverse reactions and their frequency;
Overall results of the clinical trial;
Comments on the outcome of the clinical trial;
Indication if follow up clinical trials are foreseen;
Indication where additional information could be found.